• miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.

    Thumbnail Image

    Files

    Corcoran et al. 2014 - JEV.pdf (84.54 KB)

    Date

    2014

    Authors

    Journal Title

    Journal ISSN

    Volume Title

    Publisher

    Access

    openAccess

    Embargo end date

    Citation

    Corcoran C, Rani S, Prencipe M, O'Neill A, Watson W, O'Driscoll L., miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression., J. Extracellular Vesicles., 3, 24214, 2014, 360 - 360

    Abstract

    Description

    PUBLISHED

    URI

    http://hdl.handle.net/2262/76722

    Collections

    Pharmacy and Pharmaceutical Sciences (Scholarly Publications)
    RSS Feeds

    Endorsement

    Review

    Supplemented By

    Referenced By

    Keywords

    Author's Homepage: http://people.tcd.ie/lodrisc

    Author: O'Driscoll, Lorraine

    Other Titles: J. Extracellular Vesicles.
    Type of material: Published Abstract